Literature DB >> 22640860

Words of wisdom. Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.

Thomas W Flaig1, Dan Theodorescu.   

Abstract

Entities:  

Year:  2012        PMID： 22640860      PMCID： PMC4024709          DOI： 10.1016/j.eururo.2012.04.014

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment.

Authors:  Steven Christopher Smith; Alexander Spyridon Baras; Garrett Dancik; Yuanbin Ru; Kuan-Fu Ding; Christopher A Moskaluk; Yves Fradet; Jan Lehmann; Michael Stöckle; Arndt Hartmann; Jae K Lee; Dan Theodorescu
Journal:  Lancet Oncol       Date:  2011-01-20       Impact factor: 41.316

2.  International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Authors:  Gareth Griffiths; Reginald Hall; Richard Sylvester; Derek Raghavan; Mahesh K B Parmar
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

Review 3.  The COXEN principle: translating signatures of in vitro chemosensitivity into tools for clinical outcome prediction and drug discovery in cancer.

Authors:  Steven C Smith; Alexander S Baras; Jae K Lee; Dan Theodorescu
Journal:  Cancer Res       Date:  2010-02-16       Impact factor: 12.701

4.  Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.

Authors:  H Barton Grossman; Ronald B Natale; Catherine M Tangen; V O Speights; Nicholas J Vogelzang; Donald L Trump; Ralph W deVere White; Michael F Sarosdy; David P Wood; Derek Raghavan; E David Crawford
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.